Trials / Unknown
UnknownNCT03742856
A Multi-omics Study of Epithelial Ovarian Cancer
A Multi-omics Study on the Invasiveness of Epithelial Ovarian Cancer
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (estimated)
- Sponsor
- Lei Li · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study aims to analyze the multi-omics results between epithelial ovarian cancer (EOC) patient with different FIGO stages and pathological subtypes. The multi-omics profiles include whole exome sequencing, analysis of transcriptomics and metabolomics. A comprehensive multi-omics will reveal the invasiveness and tumorigenesis of EOC.
Conditions
- Epithelial Ovarian Cancer
- Tumor Invasiveness
- Whole Exome Sequencing
- Transcriptomics
- Metabolomics
- Tumorigenesis
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | A multi-omics analysis | A multi-omics analysis including whole exome sequencing, transcriptomics and metabolomics. |
Timeline
- Start date
- 2018-11-10
- Primary completion
- 2020-11-23
- Completion
- 2020-11-23
- First posted
- 2018-11-15
- Last updated
- 2018-11-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03742856. Inclusion in this directory is not an endorsement.